| Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous … J Albert, B Abrahamsson, K Nagy, E Aurelius, H Gaines, G Nyström, ... Aids 4 (2), 107-112, 1990 | 535 | 1990 |
| Human T‐cell leukemia virus type I: induction of syncytia and inhibition by patients' sera K Nagy, P Clapham, R Cheingsong‐Popov, RA Weiss International Journal of Cancer 32 (3), 321-328, 1983 | 269 | 1983 |
| Productive infection and cell-free transmission of human T-cell leukemia virus in a non-lymphoid cell line. P Clapham, K Nagy, R Cheingsong-Popov, M Exley, RA Weiss Science 222, 1125, 1983 | 251 | 1983 |
| Update on biofilm infections in the urinary tract P Tenke, B Köves, K Nagy, SJ Hultgren, W Mendling, B Wullt, M Grabe, ... World journal of urology 30, 51-57, 2012 | 247 | 2012 |
| Pseudotypes of human T-cell leukemia virus types 1 and 2: neutralization by patients' sera. P Clapham, K Nagy, RA Weiss Proceedings of the National Academy of Sciences 81 (9), 2886-2889, 1984 | 198 | 1984 |
| Low prevalence in the UK of HTLV-I and HTLV-II infection in subjects with AIDS, with extended lymphadenopathy, and at risk of AIDS RS Tedder, DC Shanson, DJ Jeffries, R Cheingsong-Popov, A Dalgleish, ... The Lancet 324 (8395), 125-128, 1984 | 152 | 1984 |
| Systematic review of comparative studies assessing the toxicity of pesticide active ingredients and their product formulations K Nagy, RC Duca, S Lovas, M Creta, PTJ Scheepers, L Godderis, B Ádám Environmental Research 181, 108926, 2020 | 146 | 2020 |
| Is MRSA more virulent than MSSA? F Rozgonyi, E Kocsis, K Kristóf, K Nagy Clinical microbiology and infection 13 (9), 843-845, 2007 | 98 | 2007 |
| Population trends of common breeding and wintering birds in Hungary, decline of longdistance migrant and farmland birds during 1999–2012 T Szép, K Nagy, Z Nagy, G Halmo Ornis Hungarica 20 (2), 13-63, 2012 | 96 | 2012 |
| Democracy, revolution, self-determination: selected writings I Bibó, K Nagy, AA Boros-Kazai (No Title), 1991 | 91 | 1991 |
| Antiviral activity of human immunodeficiency virus type 1 protease inhibitors in a single cycle of infection: evidence for a role of protease in the early phase K Nagy, M Young, C Baboonian, J Merson, P Whittle, S Oroszlan Journal of virology 68 (2), 757-765, 1994 | 84 | 1994 |
| Use of renewable energy sources in light of the “New Energy Strategy for Europe 2011–2020” K Nagy, K Körmendi Applied Energy 96, 393-399, 2012 | 83 | 2012 |
| Alternative stabilities of a proline‐rich antibacterial peptide in vitro and in vivo PB Noto, G Abbadessa, M Cassone, GD Mateo, A Agelan, JD Wade, ... Protein Science 17 (7), 1249-1255, 2008 | 77 | 2008 |
| Prevalence and distribution of permanent canine agenesis in dental paediatric and orthodontic patients in Hungary N Rózsa, K Nagy, Z Vajó, K Gábris, A Soós, M Alberth, I Tarján The European Journal of Orthodontics 31 (4), 374-379, 2009 | 74 | 2009 |
| Envelope properties of human T-cell leukemia viruses RA Weiss, P Clapham, K Nagy, H Hoshino Human T-Cell Leukemia Virus, 235-246, 1985 | 72 | 1985 |
| Extended-spectrum beta-lactamase-producing Klebsiella spp. in a neonatal intensive care unit: risk factors for the infection and the dynamics of the molecular … K Kristóf, D Szabó, JW Marsh, V Cser, L Janik, F Rozgonyi, A Nobilis, ... European Journal of Clinical Microbiology & Infectious Diseases 26, 563-570, 2007 | 69 | 2007 |
| Results of space experiment program" Interferon". I. Production of interferon in vitro by human lymphocytes aboard space laboratory Solyut-6 (" Interferon I") and influence of … M Tálas, L Batkai, I Stöger, L Nagy, L Hiros, I Konstantinova, M Rykova, ... Acta Microbiologica Hungarica 30 (1), 53-61, 1983 | 62 | 1983 |
| Clinical microbiology of early-onset and late-onset neonatal sepsis, particularly among preterm babies K Kristóf, E Kocsis, K Nagy Acta microbiologica et immunologica Hungarica 56 (1), 21-51, 2009 | 60 | 2009 |
| Imported PER-1 producing Pseudomonas aeruginosa, PER-1 producing Acinetobacter baumanii and VIM-2-producing Pseudomonas aeruginosa strains in … D Szabó, J Szentandrássy, Z Juhász, K Katona, K Nagy, L Rókusz Annals of clinical microbiology and antimicrobials 7, 1-5, 2008 | 60 | 2008 |
| Fitness cost associated with resistance to fluoroquinolones is diverse across clones of Klebsiella pneumoniae and may select for CTX-M-15 type extended … Á Tóth, B Kocsis, I Damjanova, K Kristóf, L Jánvári, J Pászti, R Csercsik, ... European journal of clinical microbiology & infectious diseases 33, 837-843, 2014 | 58 | 2014 |
Paul ClaphamProfessor of Molecular Medicine, University of Massachusetts Medical SchoolVerified email at umassmed.edu
